[Generalized anxiety disorders (GAD)--a neglected illness? Background und aims of the GAD-P study].
In the past Generalized anxiety disorder (GAD)--previously classified as anxiety neurosis--was regarded as not being a separate diagnostic entity. On the basis of new explicit criteria for GAD in the 90ies, GAD-specific pharmacological (i.e. SNRI) and psychological treatments with improved efficacy have become available. The Generalized Anxiety and Depression in Primary care study (GAD-P) investigates the prevalence of GAD in primary care settings and evaluates the patterns of care provided. Aims, methods and findings of the GAD-P study are described in this supplement.
Wittchen
H U
HU
Institut für Klinische Psychologie und Psychotherapie der TU Dresden und Max-Planck-Institut für Psychiatrie, München.
Linden
M
M
Schwarzer
W
W
Riemann
D
D
Boerner
R J
RJ
Bandelow
B
B
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D003511:Cyclohexanols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D008875:Middle Aged; D015995:Prevalence; D011320:Primary Health Care; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D011795:Surveys and Questionnaires; D000069470:Venlafaxine Hydrochloride
D014151:Anti-Anxiety Agents; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride
Generalisierte Angststörungen (GAS)--Ein vernachlässigtes Krankheitsbild? Hintergrund und Zielsetzung der GAD-P-Studie.